Psychiatric and cognitive changes are common in patients with Parkinson's disease and have key clinical consequences but, despite this, these symptoms are often under-diagnosed and under-treated, leading to increased morbidity and costs. With chapters focused on the major neuropsychiatric features, Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders rectifies this deficit. Written by experts in the field, with a consistent focus on relevant clinical knowledge, it provides a comprehensive overview including all the major behavioral changes associated with movement disorders. The book provides broad, in-depth, accurate and up-to-date scientific information as well as crucial understanding and practical tools to help patients. The book is essential reading for clinicians working in neurology, psychiatry and geriatric medicine.
Recenzijas
'This is a first-rate book on the neuropsychiatry of Parkinson's disease. It should be required reading for clinicians who are involved in the treatment of patients with this illness.' Doody's Notes
Papildus informācija
A broad and in-depth discussion of the important, but still uninformed, field of behavioral disturbances associated with Parkinson's disease.
|
|
|
vii | |
| Preface |
|
xi | |
|
Section 1 General aspects |
|
|
|
1 Overview of Parkinson's disease: epidemiology, diagnosis, course, medical and surgical management |
|
|
1 | (13) |
|
|
|
|
|
2 Parkinson's disease: pathology, anatomy, and behavior |
|
|
14 | (11) |
|
|
|
|
|
3 The genetics of behavior and cognition in Parkinson's disease |
|
|
25 | (15) |
|
Caroline H. Williams-Gray |
|
|
|
|
4 The boundaries of Parkinson's disease dementia and dementia with Lewy bodies |
|
|
40 | (13) |
|
|
|
Section 2 Diagnosis and biomarkers |
|
|
|
5 Cognitive assessment in Parkinson's disease |
|
|
53 | (12) |
|
|
|
|
|
|
|
6 Clinical assessment: mood and motivation |
|
|
65 | (8) |
|
|
|
7 Imaging and behavior in Parkinson's disease: structural imaging |
|
|
73 | (16) |
|
|
|
|
|
|
|
8 Imaging and behavior in Parkinson's disease: functional imaging |
|
|
89 | (8) |
|
|
|
9 Diagnosis and biomarkers: CSF |
|
|
97 | (12) |
|
|
|
|
|
Section 3 Specific neuropsychiatric disorders |
|
|
|
|
|
109 | (10) |
|
|
|
|
|
|
|
119 | (12) |
|
|
|
|
|
|
|
131 | (9) |
|
|
|
13 Impulse control disorders and related behaviors |
|
|
140 | (13) |
|
|
|
|
|
|
|
153 | (10) |
|
|
|
|
|
15 Early cognitive impairment |
|
|
163 | (14) |
|
|
|
|
|
16 Parkinson's disease dementia |
|
|
177 | (15) |
|
|
|
|
|
|
|
|
|
192 | (19) |
|
|
|
|
|
|
|
|
|
|
18 Drug treatment and behavior |
|
|
211 | (19) |
|
|
|
|
|
|
|
19 Surgical treatment and behavior |
|
|
230 | (14) |
|
|
|
|
|
20 Clinical trials for psychotropic agents in Parkinson's disease using psychosis as a model |
|
|
244 | (11) |
|
|
|
|
|
|
|
|
21 The impact of neuropsychiatric symptoms on quality of life in Parkinson's disease |
|
|
255 | (6) |
|
|
|
|
|
22 Neuropsychiatric and cognitive disorders in other parkinsonian disorders |
|
|
261 | (14) |
|
|
|
|
|
|
|
23 Neuropsychiatric aspects of the on/off phenomenon |
|
|
275 | (10) |
|
|
|
|
|
24 Treatment of neuropsychiatric disturbances in Parkinson's disease: future prospects and strategies |
|
|
285 | (7) |
|
|
|
|
| Index |
|
292 | |
Dag Aarsland MD is Head of Research, Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger and Professor of Geriatric Psychiatry, University of Oslo, School of Medicine, Oslo, Norway. Jeffrey Cummings MD is Director of the Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada and Cleveland, OH, USA. Daniel Weintraub MD is Assistant Professor of Psychiatry at the University of Pennsylvania and Fellow at the University of Pennsylvania Institute of Aging, Philadelphia, PA, USA. Ray Chaudhuri MD is Consultant Neurologist and Professor in Neurology/Movement Disorders at King's College Hospital NHS Foundation Trust, London, UK.
Biežāk uzdotie jautājumi par e-grāmatām